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Abstract
The long-standing paradigm that all peroxisomal proteins are imported
post-translationally into pre-existing peroxisomes has been challenged
by the detection of peroxisomal membrane proteins (PMPs) inside the
endoplasmic reticulum (ER). In mammals, the mechanisms of ER entry
and exit of PMPs are completely unknown. We show that the human
PMP PEX3 inserts co-translationally into the mammalian ER via the
Sec61 translocon. Photocrosslinking and fluorescence spectroscopy
studies demonstrate that the N-terminal transmembrane segment
(TMS) of ribosome-bound PEX3 is recognized by the signal recogni-
tion particle (SRP). Binding to SRP is a prerequisite for targeting of the
PEX3-containing ribosome•nascent chain complex (RNC) to the translo-
con, where an ordered multistep pathway integrates the nascent chain
into the membrane adjacent to translocon proteins Sec61α and TRAM.
This insertion of PEX3 into the ER is physiologically relevant because
PEX3 then exits the ER via budding vesicles in an ATP-dependent pro-
cess. This study identifies early steps in human peroxisomal biogenesis
by demonstrating sequential stages of PMP passage through the mam-
malian ER.
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The significance of peroxisomes in cellular metabolism
is illustrated by the existence of severe inherited human
diseases that result from the failure of peroxisomal bio-
genesis (1,2). More than 30 proteins (termed peroxins) are
involved in peroxisomal assembly across species (reviewed
in 3–5), but only three are key players in early peroxisomal
membrane biogenesis. PEX19 is a soluble protein that
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acts as receptor and chaperone for newly synthesized
peroxisomal membrane proteins (PMPs) in the cytosol
(6). The integral PMP PEX16 mediates the endoplasmic
reticulum (ER)-to-peroxisome trafficking of PMPs (7,8),
but homologues are absent in most yeast species (9).
The PEX3 PMP is highly conserved among species and
has been proposed to be the docking factor for cytosolic
PEX19•cargoPMP complexes (10,11). In yeast, PEX3 is
also involved in organelle inheritance and peroxisomal
autophagic degradation (pexophagy) (12,13).
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Peroxisomes have long been considered to be autonomous
organelles that arise exclusively by growth and division
of pre-existing peroxisomes (14,15). However, convincing
evidence has recently shown that at least a subpopulation
of PMPs in yeast (16–22), plant (23) and vertebrate
cells (24–27) are targeted first to the ER prior to being
transported to the peroxisomes via an ER-derived vesicle
carrier (28–30). This ER-mediated biogenesis pathway
also emphasized the key roles of PEX3 and PEX19 in
early peroxisomal assembly, due to their newly identified
functions in intra-ER sorting of PMPs, and the budding
of preperoxisomal vesicles (19,22,28,29). Eventually, the
combined evidence that certain PMPs are sorted either
indirectly through the ER or directly to pre-existing per-
oxisomes evolved into the semiautonomous model of
peroxisomal biogenesis (23), where both pathways are
supposed to operate simultaneously (3,31–34).
As a prerequisite to understanding the early ER-mediated
steps in peroxisomal biogenesis, it is essential to ascertain
how peroxins are targeted to and inserted into the ER
membrane. For the small group of tail-anchored PMPs,
two pathways have been identified as being involved:
Insertion of mammalian PEX26 is mediated by PEX19 and
PEX3 (35), whereas yeast tail-anchored PMPs are most
likely post-translationally inserted via the GET3 pathway
(20,36). However, the majority of PMPs are polytopic or
type I/II integral membrane proteins. In yeast, such PMPs
appear to be inserted through the yeast Sec61p translocon
(20,21) that serves as the primary ER entry point for
integral membrane and secretory proteins. Depending
on its exact protein composition, the yeast Sec61p com-
plex promotes co- and post-translational translocation
of proteins (37,38). Which of these pathways is taken
for the translocation of yeast PMPs is unknown, because
previous studies (20,21) did not reveal any mechanistic
details about how the yeast Sec61p complex facilitates
PMP insertion into the ER bilayer. In addition, it remains
unresolved how yeast or mammalian PMPs are selected
for ER insertion rather than being targeted to pre-existing
peroxisomes. Making things even more complicated is
the fact that the underlying molecular mechanisms may
be different in species that are evolutionarily diverse. For
instance, the function and topology of a critical compo-
nent in early human peroxisomal biogenesis, PEX16 (39),
varies between species: it is an integral membrane protein
functioning as a PMP receptor in mammals (11,25), a
peripheral membrane protein involved in peroxisomal
fission in Yarrowia lipolytica (40), and most yeast species
lack a PEX16 homologue (41,42). Hence, it is not always
appropriate to extrapolate the knowledge gained from one
organism to another evolutionarily diverse species (43),
especially for complex mechanisms such as those that
facilitate the ER targeting and insertion of PMPs.
With regard to their important role in human metabolism,
surprisingly little is known about the passage of PMPs
through the mammalian ER, including the identity of the
translocon, if any, that facilitates PMP membrane insertion.
In addition, it is not known whether ER-derived vesicles
play a role in mammalian PMP trafficking to peroxisomes,
and no suitable in vitro system has been established to
address this issue. In this study, we identify sequential
stages in the co-translational biogenesis of a human PMP,
PEX3, as it enters and exits the mammalian ER. We show
for the first time that the signal recognition particle (SRP)
targets a peroxisomal integral membrane protein to the ER,
and that PEX3 integration into the mammalian ER mem-
brane occurs co-translationally at the Sec61-translocon
in a multistep process. We also establish a mammalian
cell-free membrane budding assay as an experimental plat-
form to reveal that PMP-containing vesicles are released
from the ER in an energy-dependent reaction.
Results and Discussion
Approach
Convincing evidence has been provided that certain mam-
malian PMPs (24,25,27,44), including human PEX3 (26),
are first targeted to the ER on route to the peroxisome. In
light of its important role in early peroxisomal biogene-
sis (45), we have focused on identifying the mechanisms
involved in human PEX3 targeting to and insertion into the
mammalian ER membrane. Thus, we used an in vitro trans-
lation system well established for studying ER targeting
(46,47), the co-translational SRP/translocon-dependent
targeting and integration of nascent proteins into the ER
membrane (37,38,48,49), and transient nascent protein
interactions during translation (50).
As soon as a cleavable signal sequence or an uncleaved
signal-anchor sequence of an integral membrane protein
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emerges from the ribosome, it is recognized and bound by
the SRP (reviewed in 37, 38). This interaction transiently
arrests protein synthesis until the SRP interacts with its
ER-resident receptor to target the ribosome•nascent chain
complex (RNC) to a translocon in the ER membrane. Two
hydrophobic regions, HR1 and HR2 (Figure 1A), have been
identified in human PEX3 (51). Since HR1 emerges first
from the ribosomal exit tunnel during ribosomal synthesis
(Figure 1B), its interactions were examined using environ-
mentally sensitive probes. A photoreactive crosslinking
probe (5-azido-2-nitrobenzoyl, ANB) or a fluorescent dye
(7-nitrobenz-2-oxa-1,3-diazole, NBD) was positioned in
the middle of HR1 by in vitro translation of a human PEX3
mRNA in which codon 25 was replaced by an amber stop
codon (PEX3G25amb, see also Figure 3A). Addition of amber
suppressor aminoacyl-tRNA analogs εANB-Lys-tRNAamb
or εNBD-Lys-tRNAamb (52–54) to the translation then
allowed selective labeling of HR1 with the probe. When
a truncated PEX3 mRNA transcript lacking a final stop
codon was translated, all nascent chains in the resulting
RNC sample had the same length and remained attached
to the ribosome as peptidyl-tRNA because normal termi-
nation was prevented. By varying the length of truncated
mRNA added to translations, RNCs with different nascent
chain lengths provided a series of static snapshots of
sequential stages in PMP membrane targeting and inte-
gration. Nascent chains are designated P(x)-PEX3(n) to
represent PEX3 nascent chains with a length of n residues
and a probe P at residue x. Since the ribosomal exit tunnel
encloses roughly 40 residues of an emerging nascent chain,
and HR1 extends until residue 36 of PEX3, a RNC with
a nascent chain of approximately 80 residues is necessary
to fully expose HR1 to the cytosol. Hence, initial experi-
ments were performed with PEX3(93)-RNCs (Figure 1B),
thereby ensuring sufficient spatial flexibility and distance
between HR1 and the ribosome.
SRP binds the N-terminal HR1 of ribosome-bound
nascent PEX3
Photoreactive ANB was introduced into HR1 by trans-
lating a truncated PEX3G25amb mRNA in the presence
of εANB-Lys-tRNAamb; the control sample received
Lys-tRNAamb. The resulting ANB(25)-PEX3(93) and
PEX3(93) RNCs were photolyzed, and a prominent pho-
toadduct of approximately 65 kDa, which represents the
molecular weigh of SRP54 (54 kDa) covalently linked to
the PEX3 93mer (11 kDa), was formed only in the sample
with ANB (Figure 1C). Photoadducts were then analyzed
by immunoprecipitation using antibodies specific for
SRP54, the signal sequence-binding component of SRP
(55,56). Since [35S]Met-labeled ANB(25)-PEX3(93) chains
reacted covalently with SRP54 (Figure 1C), the photore-
active ANB in HR1 was adjacent to SRP54. On the other
hand, the shorter ANB(25)-PEX3(61) RNC, which does
not expose HR1 completely to the cytosol, did not form
covalent photoadducts with SRP54 (Figure S1, Supporting
Information). Thus, HR1 was recognized and bound by
SRP as it emerged from the ribosome.
The association of SRP with PEX3-containing RNCs was
also detected using a NBD fluorescent probe in HR1. NBD
was chosen because its emission properties change dra-
matically upon moving from an aqueous to a hydrophobic
environment (52), and we previously showed that NBD
was a sensitive spectral sensor of SRP association with a
RNC signal sequence (53). NBD was introduced at position
25 of HR1 by translating truncated PEX3G25amb mRNA
in the presence of εNBD-Lys-tRNAamb. When canine
SRP was added to purified NBD(25)-PEX3(93)-RNCs,
a significant increase in NBD emission intensity was
observed (Figure 1D, top). In contrast, no increase in
emission intensity was detected when only buffer was
added to NBD(25)-PEX3(93) RNCs (Figure S2) or when
SRP was incubated with NBD(25)-PEX3(42) RNCs
(Figure 1D, bottom) with HR1 still inside the riboso-
mal exit tunnel (Figure 1B). Moreover, SRP binding to
NBD(25)-PEX3(93)-RNCs was saturable, as shown by the
dependence of sample emission intensity on the concen-
tration of SRP (Figure 1E). These data therefore provide
the first direct evidence that a nascent peroxisomal integral
membrane protein is recognized and bound by the SRP as
soon as it emerges form the ribosomal exit tunnel.
HR1 functions as signal-anchor sequence
in SRP-dependent PEX3 targeting to and integration
into the ER membrane
The HR1 interaction with SRP indicates that the nonpolar
HR1 acts as a signal sequence. Does HR1 also function
as a transmembrane segment (TMS) to anchor PEX3
in the membrane? PEX3 HR segments were engineered
into the Escherichia coli inner membrane protein leader
peptidase (57) (Figure 2A), and the glycosylation pattern


































































































Figure 1: HR1 of PEX3 binds to SRP. A) Schematic representation of full-length PEX3. Two predicted hydrophobic α-helical regions
are indicated by black (HR1) and white (HR2) boxes. B) A probe (the photoreactive crosslinker ANB or the fluorescent dye NBD)
is incorporated into HR1 of ribosome-tethered nascent PEX3. The HR1 of short nascent chains (e.g. 42mer) is located within the
ribosomal exit tunnel, whereas longer chains (e.g. 93mer) expose HR1 to the cytosol and hence to the SRP. C) Photocrosslinking of
PEX3 to SRP. [35S]Met-PEX3(93)-RNCs with or without a single ANB at residue 25 were photolyzed and then analyzed by SDS-PAGE
and phosphorimaging either directly (Totals, 1/20 aliquot) or after immunoprecipitation with antibodies directed against SRP54. M:
molecular weight marker. D) Fluorescence-detected SRP binding to PEX3. Emission scans (λex = 468 nm) of purified NBD(25)-PEX3(93)-
or NBD(25)-PEX3(42)-RNCs were performed in buffer A before (−SRP) and immediately after the addition of purified canine SRP (+SRP).
E) Purified NBD(25)-PEX3(93)-RNCs were titrated with the indicated total concentrations of SRP. The observed change in emission
intensity (λex = 468 nm; λem = 528 nm) is ΔF, and the initial fluorescence intensity of the sample without SRP is designated F0. The
averages of at least three independent experiments are shown, with error bars indicating the SD.
revealed that isolated HR1, but not HR2, was efficiently
integrated into the ER membrane (Figure 2B). Moreover,
single-glycosylation of a Lep-derived chimera that con-
tained both HRs (connected by their natural-occurring
linker sequence) suggests that only one bilayer-spanning
segment (HR1) exists within the HR1-HR2 fragment
of PEX3 (Figure 2B). Furthermore, carbonate extrac-
tion of PEX3 and a derivative lacking HR1 (Figure 2C)
showed that HR1 is necessary (Figure 2D) and sufficient
(Figure S3) for stable insertion of PEX3 into the ER
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Figure 2: HR1 is responsible for ER membrane insertion of PEX3. A) Schematic representation of E. coli leader peptidase
(Lep) constructs. A putative TMS (shaded) is engineered into the P2 domain flanked by two glycosylation acceptor sites (G1 and G2).
Membrane integration of the TMS prevents enzymatic glycosylation of G2 on the lumenal side of the membrane (I), whereas both sites
are glycosylated when a TMS does not insert into the membrane (II). In the latter case, ER-lumenal P2 is also protected from Proteinase
K (PK) treatment. The model of a Lep construct containing both HRs of PEX3 (PEX3 HR1-2) suggests that only HR1 is inserted into the
membrane. B) Insertion of PEX3 HR1 (residues 14–36), HR2 (residues 108–130), or HR1-HR2 (residues 14–130) fragments into the ER
bilayer. PEX3-HR-Lep chimeras or a translocated control (construct no. 67; 58) were translated in RRL in either the presence or absence
of column-washed rough microsomes (CRM). [35S]Met-labeled proteins were analyzed directly or treated with PK. Unglycosylated ( ),
mono- ( ), double-glycosylated ( ), and P2-containing protease-protected fragments (*) are indicated. C) Scheme of full-length and
truncated PEX3 lacking the N-terminal 66 residues (Δ66PEX3). D) Full-length PEX3 is anchored in the ER bilayer. [35S]Met-PEX3 was
translated in RRL supplemented with CRM, and products were subjected to sodium carbonate extraction at pH 11.5 and separated
by centrifugation. The supernatant (Sn), the membrane pellet (Pe) and an untreated aliquot (To) are shown. Numbers indicate the
average amount of PEX3 or Δ66PEX3 in the supernatant and membrane pellet fractions, respectively. The averages± SD of at least
three independent experiments are shown. E) Orientation of ER-inserted PEX3. Full-length PEX3 or secreted bovine prolactin (BPL) was
translated as above in either the absence or presence of CRM. Translation products were analyzed directly or treated with PK. pre, BPL
with an uncleaved signal sequence.
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bilayer. Finally, protease sensitivity revealed that the large
C-terminal domain of ER-inserted PEX3 is exposed to the
cytosol (Figure 2E), a topology previously described
for peroxisomal-localized PEX3 (51,59). Since ER
membrane-integrated and non-inserted PEX3 had iden-
tical molecular masses (Figure 2D,E), the N-terminal
hydrophobic HR1 of PEX3 acts as a non-cleavable
signal-anchor TMS that is recognized by SRP.
Following SRP•RNC docking at the ER membrane, the
Sec61 translocon mediates both the transport of sol-
uble proteins into the ER lumen and the insertion of
integral membrane proteins laterally into the ER bilayer
(38). The mammalian Sec61 translocon is composed
of four core proteins, Sec61α,β,γ and the translocat-
ing chain-associating membrane protein (TRAM; 48).
To examine SRP dependence of PEX3 targeting to the
translocon, PEX3-RNCs were translated in a wheat germ
extract that has such a low endogenous content of SRP
that RNC targeting to canine column-washed rough
microsomes (CRM) is dependent on added canine SRP
(55,60). ANB(25)-PEX3(93) RNCs were prepared in the
presence of CRM, and either the presence or absence
of SRP. After photolysis and immunoprecipitation using
antibodies specific for Sec61α, covalent photoadducts
between Sec61α and PEX3 nascent chains were observed
only in the presence of SRP (Figure 3B). No photoadducts
were observed in the absence of the photoreactive probe
(data not shown). Thus, SRP is required to target nascent
PEX3 to the translocon.
PEX3 interacts with translocon proteins Sec61𝛂
and TRAM in a defined and ordered multistep sequence
To further characterize PEX3 HR1 interactions at
the ER translocon, we used a high-resolution pho-
tocrosslinking approach. Parallel samples of same
length ANB(23)-PEX3(79), ANB(24)-PEX3(79) and
ANB(25)-PEX3(79) integration intermediates were gener-
ated and photolyzed, and the extent of photocrosslinking
to translocon proteins was determined by immunopre-
cipitation with antibodies specific for Sec61α and TRAM.
The ANBs incorporated at three sequential residues
within HR1 project from three different sides of the TMS
α-helix (Figure 3A). If HR1 is randomly oriented when
it is proximal to Sec61α, then all three probes should
react equally with Sec61α and/or TRAM. However, if an
asymmetric photocrosslinking pattern is observed, then
HR1 must be held in a fixed orientation adjacent to Sec61α
and/or TRAM (54). Since only probes at residue 25 of
PEX3 photocrosslinked to Sec61α (Figure 3C), probes
at both positions 24 and 25 photocrosslinked to TRAM
(Figure 3D), and probes at residue 23 photocrosslinked
to neither translocon protein, the asymmetry of pho-
tocrosslinking reveals that HR1 is bound and held at a
specific site within the translocon.
HR1 proximity to translocon proteins was then examined
as a function of nascent chain length. Since an εANB-Lys
at PEX3 residue 25 photocrosslinked to both Sec61α and
TRAM, ANB(25)-PEX3 RNCs with increasing nascent
chain lengths were prepared in parallel, photolyzed and
analyzed by immunoprecipitation. When nascent chain
length increased beyond 93 residues, HR1 was no longer
adjacent to Sec61α (Figure 3E,F). TRAM-containing pho-
toadducts were observed with nascent chain lengths of
93 and 122, 148 to a lesser extent (Figure 3F), and not at
all for nascent chains 192 or more residues (Figure S4).
Since HR1 was adjacent to TRAM, but not to Sec61α,
at 122 residues, HR1 was retained next to TRAM longer
than to Sec61α, consistent with earlier data showing a
TMS passing sequentially from Sec61α to TRAM dur-
ing integration at the translocon (61,62). Human PEX3
therefore inserts co-translationally into the ER membrane
via a SRP-dependent and defined translocon-mediated
multistep pathway.
In yeast, the only peroxin mRNA that co-localized at the
ER was that of PEX3 (63), a result indirectly suggesting
that the Sec61p translocon facilitates the co-translational
insertion of PEX3 into the yeast ER. Other recent studies
support the involvement of the yeast Sec61p translocon
in PMP integration (20,21), whereas previous reports (64)
came to the opposite conclusion. By taking all differences
in the experimental setups into account, there is now an
increasing appreciation that the yeast Sec61p translocon is
required for PMP insertion into the yeast ER (reviewed in
31, 32, 65, 66). However, several key issues remain unre-
solved. It is not known how PMPs reach the translocon in
yeast, or whether PMP insertion into the yeast ER occurs
co- or post-translationally (21). Similarly, it was not known
whether the Sec61 translocon was required for PMP inser-
tion into the ER in mammals. But here we show for the first
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time that a N-terminal TMS of a nascent PMP is recognized
by SRP as it emerges form the ribosome (Figure 1), and that
SRP is required to target the PMP-containing RNC to the
translocon (Figure 3). These results are in line with recent
data showing that the first TMS of PEX16 is necessary
for its targeting to the ER(8). In addition, our data show
that the nascent chain of the mammalian PMP PEX3 is
co-translationally inserted into the ER bilayer adjacent to
the translocon proteins Sec61α and TRAM in a multistep
process (Figure 3). These results therefore establish the
Sec61 translocon as ER entry point for mammalian PMPs,
as well as providing mechanistic details of PMP targeting
to and insertion into the mammalian ER membrane.
Does every human PEX3 insert into the ER membrane
via the SRP- and translocon-mediated pathway? Given the
sub-stoichiometric number of SRPs relative to ribosomes
(1–2 SRPs/100 yeast ribosomes (67), and 5–8 SRPs/100
mammalian ribosomes (68)), it is certainly possible that
PEX3 molecules may escape recognition by SRP and be
inserted post-translationally into peroxisomes (11) or
the ER (25,26). On the other hand, the co-translationally
inserted PEX3 in the ER may serve as docking factor
for PEX19•cargoPMP complexes (10,11) and thereby
concentrate other PMPs or PMP sub-complexes (30) in a
spatially defined area of the ER. The initial co-translational
insertion of human PEX3 at a Sec61 translocon would
therefore be a critical and essential step in seeding the
mammalian ER with peroxins.
PEX3 exits the ER via budded vesicles
Is PEX3 integration into the ER membrane a precursor to
PEX3 transport to the peroxisome? If so, one would pre-
dict that PEX3 is segregated into specific regions of the ER
membrane for budding and transport to the peroxisome
(27). A cell-free vesicle budding assay recently established
in yeast (28,29) shows that PMP-containing carrier vesicles
are released from the ER in a cytosol- and ATP-dependent
process. To determine whether human PEX3 is packed
into vesicles that bud from mammalian ER membranes,
full-length PEX3 was translated in vitro in the presence of
canine ER microsomes. Following translation, membranes
were collected and washed extensively to remove any
peripherally attached PEX3. These microsomes were then
used as donor membranes to study the ER exit of PEX3 in
the presence of rabbit reticulocyte lysate (RRL), ATP and
an ATP-regenerating system. After the budding reaction,
the larger and more dense donor microsomal membranes
were removed by medium-speed centrifugation. PEX3 was
then detected in the supernatant fraction of samples con-
taining RRL and ATP, but not in the supernatant of samples
lacking either cytosol or ATP (Figure 4A). Budded PEX3
could be collected by high-speed centrifugation, was resis-
tant to carbonate extraction, and was solubilized in deter-
gent (Figure 4B), thereby indicating that PEX3 was local-
ized in a membrane of small vesicles. Since 36± 4% of the
total integrated PEX3 was recovered in the supernatant in
the presence of cytosol and ATP (Figure 4A), PEX3 was
apparently selected and preferentially transferred to the
small ER-derived vesicles.
Great attention has been paid to the mechanisms involved
in the vesicular trafficking of PMPs from ER to per-
oxisomes in yeast. Recent studies revealed that new
peroxisomes are formed via heterotypic fusion of at
least two biochemically distinct preperoxisomal vesicle
pools that arise from the ER (30). However, the detailed
molecular basis for the budding of these preperoxisomal
Figure 3: Photocrosslinking of nascent PEX3 to the translocon proteins Sec61𝛂 and TRAM. A) Scheme and N-terminal
sequence of PEX3. Arrows indicate nascent chains of different lengths. An amber stop codon was substituted at position L23, G24 or
G25 (underlined) to position the photoreactive ANB at a single nascent chain location within HR1 (boxed). Probes project from different
sides of the TMS α-helix surface as shown in the helical wheel projection (right). B) Photocrosslinking to Sec61α is SRP-dependent.
[35S]Met-ANB(25)-PEX3(93) nascent chains were prepared in wheat germ extract supplemented with canine CRM in either the absence
or presence of canine SRP. Photoadducts were analyzed directly (Totals, 1/20 aliquot) or after immunoprecipitation with antibodies
specific for Sec61α. C–F) Photocrosslinking to Sec61α and TRAM. [35S]Met-labeled ANB(23)-PEX3, ANB(24)-PEX3 or ANB(25)-PEX3
integration intermediates of different length were translated in the presence of CRM and SRP. Photoadducts were analyzed either
directly (Totals, 1/20 aliquot) or after immunoprecipitation with antibodies directed against Sec61α or TRAM, respectively. Photoadducts
containing Sec61α ( ) or TRAM ( ) are indicated in (F). Uncropped images of (D) and (E) are shown in Figure S5.
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Figure 4: Cell-free vesicle budding of PEX3. A) Full-length [35S]Met-PEX3 was transcribed/translated in RRL in the presence of
CRM. Washed donor membranes were incubated at 30∘C in the presence of either buffer A (− lysate) or RRL. Samples were either
substituted with an ATP-regenerating system (+ATP) or treated with apyrase (−ATP). After the budding reaction, donor membranes
were removed by sedimentation, and the supernatant fraction and a 20% aliquot (Input) of the starting microsomes were analyzed.
Numbers indicate the average amount of budded PEX3± SD for at least three independent experiments. B) The supernatant of an ATP-
and lysate-containing budding reaction was subjected to high-speed (HS) centrifugation, and the pellet was resuspended in buffer A
with or without 1% (v/v) Triton X-100 or subjected to 0.1 M sodium carbonate extraction at pH 11.5. After a second centrifugation
step, the protein contents of the supernatant (Sn) and pellet (Pe) fractions were analyzed. C) Model of human PEX3 passage through
the ER. During ribosomal translation of PEX3, HR1 is recognized and bound by SRP (i). After SRP-dependent targeting of the RNC to
the ER membrane (ii) via the SRP receptor (SR), PEX3 is co-translationally integrated into the mammalian ER at the Sec61 translocon
and its associated proteins (J Domain Protein, BiP; 69) (iii). Following integration into the ER membrane, PEX3 is selectively packed into
budding vesicles in an ATP- and cytosol-dependent process (iv). PEX3-containing budded vesicles then either fuse with pre-existing
peroxisomes or initiate peroxisomal de novo synthesis (v).
structures in yeast remains unclear (70). In mammals, it
was unknown whether small ER-derived vesicles play a
role in the mammalian peroxisomal de novo biogenesis.
But our data now provide the first direct evidence that
human PMPs are actively and selectively extracted from
mammalian ER membranes in a cytosol-dependent and
ATP-consuming vesicle budding reaction. As previously
reported in yeast (19,28–30), these data are consistent
with small ER-derived vesicles playing a role in PEX3
trafficking to mammalian peroxisomes. By establishing
a mammalian cell-free budding assay, we provide a new
experimental platform that can both examine the precise
distribution and binding partners of newly inserted PMPs
in the ER, and identify the components in the cytosol that
are involved in the budding reaction. Such information
is crucial for understanding the de novo formation of
peroxisomes from the ER in mammals.
The combined data presented here establish that nascent
human PEX3 is targeted to the mammalian ER mem-
brane by SRP, integrates co-translationally at the
mammalian translocon, and then is selectively pack-
aged and extracted from the ER membrane via an energy-
and cytosol-dependent budding reaction. By experimen-
tally characterizing the entire pathway required for PEX3
passage through the ER (Figure 4C), the transient role
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of the ER in mammalian peroxisomal biogenesis has
now been demonstrated from recruitment and entry
to exit and discharge. On the other hand, it has been
reported that certain integral PMPs, including PEX3 (11),
can insert post-translationally into mature peroxisomes
(6,10,35). The existence of these two distinct pathways, the
co-translational insertion into the ER via the Sec61 translo-
con as detailed in this study, and the post-translational
insertion into mature peroxisomes (6,10,11,35), is in good
agreement with the currently widely accepted semiau-
tonomous model of peroxisomal biogenesis (3,31–34).
According to this working model, a dynamic peroxiso-
mal homeostasis is ensured by both the recruitment of
PMP-containing membranes from the ER via budded vesi-
cles and the enhanced accumulation of PMP and matrix
proteins in pre-existing peroxisomes, thereby facilitating
fast peroxisomal propagation by growth and division.
Since differences in the relative contribution of these two
routes are likely to depend on the organism or its cellular
conditions, a future challenging goal is to determine what
fraction of PMPs, and particularly PEX3 molecules, is
inserted directly into pre-existing peroxisomes instead of
transiting through the ER. While the mechanisms that
regulate when, where and how a PMP will follow a par-
ticular route are currently unknown, the data herein show
that co-translational mammalian PEX3 targeting to and
insertion into the ER membrane occurs via SRP and the
Sec61 translocon, and that PEX3 exit from the mammalian
ER occurs via budded vesicles in an ATP-dependent pro-
cess. By establishing the mechanisms of PEX3 entry into
and exit from the mammalian ER, the regulation of PEX3
trafficking can now be addressed and quantified directly.
Materials and Methods
Plasmids, mRNA, tRNA, SRP and microsomes
All PEX3 constructs originated from the plasmid pcDNA3.1/PEX3mychis
that encodes the human full-length PEX3, as previously described (51).
The introduction of a single amber stop codon at selected locations
was done using the Quikchange protocol (Agilent Technologies). Bovine
prolactin is encoded in the plasmid pSP64-BPL (71). For the mem-
brane insertion of isolated PEX3-segments, HR1 (residues 14–36), HR2
(residues 108–130) or HR1-HR2 (residues 14–130) fragments were inde-
pendently amplified and introduced into the modified E. coli leader
peptidase (Lep) sequence from the pGEM1 plasmid (58) using the
SpeI/KpnI sites. The primary sequence of each construct was confirmed
by DNA sequencing. mRNA was transcribed in vitro using SP6 RNA
polymerase and PCR-generated DNA fragments of the desired length
as before (54). Reverse primers either contained an ochre stop codon
to obtain full-length PEX3 translation products (e.g. for the budding
assay) or lacked a stop codon for the generation of RNCs. Primer
sequences are available from the authors on request. [14C]Lys-tRNAamb,
εANB-[14C]Lys-tRNAamb, εNBD-[14C]Lys-tRNAamb, canine CRM and
purified SRP from dog pancreas in SRP buffer [50 mM triethanolamine
(pH 7.5), 600 mM KOAc (pH 7.5), 6 mM Mg(OAc)2, 1 mM DTT] were
obtained from tRNA Probes. SRP concentration was determined using
ε280nm = 1.0× 106 M−1cm−1.
Cell-free translation in RRL
In vitro translation of purified mRNA (typically 25 μL, 30∘C, 40 min)
was performed in the presence of RRL (Promega), [35S]Met (0.4 μCi/μL),
and, when indicated, 4 equivalents (eq., 72) CRM. After translation, sam-
ples were either analyzed directly by SDS-PAGE and phosphorimaging
(PharosFX molecular imager, Bio-Rad), or membranes were collected by
sedimentation (Beckman TLA100 rotor; 430 000× g; 5 min; 4∘C) through
a 0.5 M sucrose cushion in buffer A [30 mM HEPES (pH 7.5), 120 mM
KOAc, 3.2 mM Mg(OAc)2]. For proteolysis experiments (Figure 2E), sam-
ples were treated with 200 μg/mL proteinase K for 30 min on ice followed
by the addition of 1 mM phenylmethylsulfonyl fluoride. For carbonate
extraction (73), membranes were incubated in carbonate buffer [0.1 M
Na2CO3 (pH 11.5)] for 15 min on ice, centrifuged (Beckman TLA100
rotor; 430 000× g; 5 min; 4∘C), washed and resuspended in carbonate
buffer. The supernatant and pellet fraction were neutralized with glacial
acetic acid and further analyzed as above.
Lep-derived constructs were transcribed and translated in the presence
of RRL, [35S]Met and canine CRM as described previously (74). Sam-
ples were analyzed by SDS-PAGE, and visualized on a Fuji FLA3000
phosphorimager using IMAGEGAUGE software. The proteinase K digestions
were performed after in vitro translation by incubation the mixture with
400 μg/mL proteinase K on ice for 40 min (Figure 2B). The reaction was
stopped by adding 2 mM phenylmethylsulfonyl fluoride. The membrane
fraction was then collected by centrifugation and analyzed by SDS-PAGE.
Photocrosslinking and immunoprecipitation
In vitro translations (typically 50 μL, 26∘C, 40 min) of truncated mRNAs
were performed in wheat germ cell-free extract (tRNA Probes) in
the presence of 40 nM canine SRP, 8 eq. CRM, [35S]Met (1.0 μCi/μL),
0.6 pmol/μL [14C]Lys-tRNAamb/εANB-[14C]Lys-tRNAamb as indicated,
and other components as described (52). Samples were photolyzed on
ice for 15 min using a 500 W mercury arc lamp (54). After photolysis,
samples were collected by sedimentation (5 min for CRM or 60 min for
free RNCs) through a 0.5 M sucrose cushion in buffer A as described
above. Pellets were resuspended in 3% (w/v) SDS and 50 mM Tris–HCl
(pH 7.5), then incubated at 55∘C for 30 min. Samples were brought up
to 500 μL with either buffer S [140 mM NaCl, 10 mM Tris–HCl (pH 7.5),
and 2% (v/v) Triton X-100] for Sec61α-specific antibodies, or buffer
T [150 mM NaCl, 1 mM EDTA, 50 mM Tris–HCl (pH 7.5), 1% (v/v)
Triton X-100] for TRAM- or SRP54-specific antibodies. Samples were
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precleared by rocking with protein A-Sepharose (Sigma-Aldrich; 40 μL;
pre-equilibrated in buffer S or T) at 4∘C for 1 h. After removal of the
beads by centrifugation, the supernatants were incubated overnight at
4∘C with affinity-purified rabbit antisera specific either for Sec61α or
TRAM (54), or for SRP54 (BD Biosciences). Protein A-Sepharose (40 μL,
pre-equilibrated with buffer S or T) was then added and incubated for
4 h at 4∘C. Sepharose beads were harvested by sedimentation and washed
twice with 750 μL of buffer S or T, followed by a final washing in the same
buffer without detergent. Samples were then analyzed by SDS-PAGE and
phosphorimaging.
Fluorescence spectroscopy
In vitro translations (500 μL total volume, 26∘C, 40 min) of truncated
mRNAs were performed in wheat germ cell-free extract in the pres-
ence of 0.6 pmol/μL εNBD-[14C]Lys-tRNAamb and other components as
described (52). To correct for the significant background signal due to
light scattering from the ribosomes, equivalent blank translation reactions
lacking NBD were prepared in parallel with [14C]Lys-tRNAamb. RNCs
were purified by gel filtration at 4∘C using a Sepharose CL-6B column
(1.5 cm inner diameter× 20 cm) and buffer A as elution buffer. A slow flow
rate was used during gel filtration to ensure the removal of noncovalently
bound fluorophores. The absorbance at 260 nm of each 550 μL fraction
was used to identify those fractions containing RNCs that elute in the void
volume, and only the leading half of the void volume peak was pooled.
After gel filtration, the absorbance at 260 nm of the two parallel samples
(one with and one without NBD) was equalized before initiating spec-
tral measurements. Steady-state fluorescence measurements were made
with either an SLM-8100 or a Spex Fluorolog-3 spectrofluorometer at 4∘C
as described previously (53). Samples (250 μL) were placed in 4× 4 mm
quartz microcells that were coated with phosphatidylcholine vesicles to
minimize protein adsorption (75). The cuvette chamber was continuously
flushed with N2 to prevent condensation of water on the microcells. Emis-
sion intensity (λex = 468 nm) was scanned at 1-nm intervals between 500
and 580 nm. Samples of purified RNCs with or without NBD in buffer
A were titrated at 4∘C by the sequential addition of known amounts of
SRP in small volumes. After each addition, the emission intensities of
the NBD and blank samples were measured after reaching equilibrium.
After blank subtraction and dilution correction, the observed change in
net NBD emission intensity (ΔF; λex = 468 nm; λem = 528 nm, bandpass
4 nm) at each point in the titration was compared with the initial intensity
(F0) of the sample in the absence of SRP.
Budding assay
Purified full-length PEX3 mRNA was translated in RRL in the presence
ER microsomes as described above. The translation (60 min, 30∘C) was
stopped by addition of puromycin (2 mM final, 20 min, 4∘C) and micro-
somes were collected by centrifugation through a 0.5 M sucrose cushion in
buffer A as above. Membranes were incubated in 2.5 M urea in buffer A for
10 min at 4∘C to remove peripherally bound PEX3 molecules. Membranes
were collected by medium-speed centrifugation (20 000× g, 10 min, 4∘C),
washed once in urea buffer, and finally washed in buffer A. Such PEX3
containing donor membranes were resuspended in buffer A, and incu-
bated with either RRL (the lysate was diluted to 60% of its original concen-
tration in the budding reaction) or an equivalent amount of buffer A. Bud-
ding reactions also contained 2 mM puromycin and either an energy gen-
erating system (final concentrations: 16 mM phosphocreatine, 2 mM ATP,
2 mM GTP, 0.016 U/μL phosphocreatine kinase) or 1 U/μL apyrase. After
incubation of the budding reaction for 60 min at 30∘C, donor membranes
were removed by medium-speed centrifugation, and the supernatant was
analyzed by SDS-PAGE and phosphorimaging. In certain cases, the super-
natant of a budding reaction was further subjected to high-speed centrifu-
gation (Beckman TLA100 rotor; 55 000 rpm; 30 min; 4∘C), and the pellet
was resuspended in either carbonate buffer or 0.25 M sucrose in buffer
A in the presence or absence of 1% (v/v) Triton X-100. After a second
high-speed centrifugation, the protein content of the supernatant and pel-
let fractions was analyzed as above.
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Supporting Information
Additional Supporting Information may be found in the online version of
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Figure S1: Photocrosslinking of PEX3(61)- and PEX3(93)-RNCs to
SRP. [35S]Met-ANB(25)-PEX3-RNCs were photolyzed and then analyzed
by SDS-PAGE and phosphorimaging either directly (Totals, 1/20 aliquot)
or after immunoprecipitation with antibodies directed against SRP54.
Photoadducts containing SRP54 ( ) are indicated.
Figure S2: SRP storage buffer does not alter the emission intensity of
fluorescence-labeled PEX3. Truncated PEX3G25amb mRNA was trans-
lated in wheat germ extract in the presence of εNBD-Lys-tRNAamb.
Emission scans (λex = 468 nm) of purified NBD(25)-PEX3(93)-RNCs
were performed in buffer A before (−SRP buffer) and immediately after
the addition of SRP storage buffer (+SRP buffer, equal volume as in
Figure 1D).
Figure S3: HR1 of PEX3 is stably anchored in the ER bilayer. A)
Schematic representation of full-length PEX3 and a C-terminally trun-
cated PEX3 variant of 79 residues length (PEX[79]). Two predicted
hydrophobic α-helical regions (HR) are indicated by black (HR1) and
white (HR2) boxes. B) PEX[79] was translated in rabbit reticulocyte lysate
in the presence of CRMs. [35S]Met-labeled translation products were sub-
jected to sodium carbonate extraction at pH 11.5. After centrifugation
(100 000× g; 20 min), the supernatant (Sn) and the membrane pellet (Pe)
were analyzed by SDS-PAGE and visualized by phosphorimaging.
Traffic 2016; 17: 117–130 127
Mayerhofer et al.
Figure S4: Photocrosslinking of PEX3 to TRAM depends on nascent
chain length. [35S]Met-labeled integration intermediates containing
ANB(25)-PEX3 nascent chains were prepared in parallel in wheat germ
extract (supplemented with canine ER microsomal membranes and
40 nM canine SRP) with lengths of 42, 61, 79, 93, 192 and 373 (full-length)
residues. After photolysis, photoadducts were immunoprecipitated with
antibodies directed against TRAM and analyzed by SDS-PAGE and
phosphorimaging.
Figure S5: Uncropped phosphorimager scans of Figure 3D,E.
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